Research Affiliations 

MUSC Health advances biomedical knowledge by serving as a setting for clinical and translational research, providing resources for conducting research and opportunities for patients to participate in research and treatment protocols.

Hollings Cancer Center – South Carolina’s Only NCI-Designated Cancer Center

Research affiliations with MUSC Health allow other health care entities to access MUSC Health-based clinical trials, either as co-participants or as direct access points for their patients.

The Hollings Cancer Center Clinical Trials Network (CTN) represents a partnership of quality cancer centers dedicated to the promotion of cancer research. By establishing a collaborative infrastructure of physicians, clinical trials offices, and patients, the CTN reaches large and diverse patient populations, which increases the rate of trial enrollment — a key to the success of any clinical trial.

The CTN caters to both the clinical trial site and research sponsor. MUSC Health can design a unique service plan to meet your organization’s needs. CTN members gain access to a number of unique clinical trials, which may include trials developed at the Hollings Cancer Center, e.g., our investigator-initiated trials. Members also have the opportunity to participate in other phase II and phase III studies made available to the CTN through MUSC Health’s academic or industrial partnerships.

MUSC Health Clinical Trials

Hollings Cancer Center Clinical Trials